Management and Control of Trichomonas vaginalis Infection: A Recent Study
Padmalaya Das
Abstract
Padmalaya Das
Abstract
Trichomonas vaginalis is the etiologic agent of trichomoniasis, the most common non-viral sexually transmitted disease (STD) in the world. The infection occurs in the female and male urogenital tract and humans are the only natural host for the parasite. In this chapter, the Management of Trichomonas vaginalis Infection as well as prevention are well described. Multidose metronidazole has been found to be superior to single-dose metronidazole for the treatment of trichomoniasis. The drug is well tolerated with minimal adverse reactions. The authors suggested that treating trichomoniasis in women with a 7-day dose of metronidazole should be the first line of treatment.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Trichomonas vaginalis is the etiologic agent of trichomoniasis, the most common non-viral sexually transmitted disease (STD) in the world. The infection occurs in the female and male urogenital tract and humans are the only natural host for the parasite. In this chapter, the Management of Trichomonas vaginalis Infection as well as prevention are well described. Multidose metronidazole has been found to be superior to single-dose metronidazole for the treatment of trichomoniasis. The drug is well tolerated with minimal adverse reactions. The authors suggested that treating trichomoniasis in women with a 7-day dose of metronidazole should be the first line of treatment.
Key concepts: Trichomonas vaginalis, Trichomonas, Medicine, Gynecology